GRI Bio GRI
NASDAQ GRI
$1.50 +0.04 (+2.55%)
As of: Oct 21, 2026 · 11:41 AM EDT

GRI Bio (GRI) EBIT Margin (2020 - 2026)

Updated

GRI Bio's EBIT Margin was -4788.00% in FY2020.

Analysis

GRI Bio (GRI) EBIT Margin (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 GRI Bio 2.75 Mn -31.53 Mn - -32,960.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32,960.00%
Mar 31, 2026 -40,060.00%
Dec 31, 2025 -53,280.00%
Sep 30, 2025 -56,083.33%
Jun 30, 2025 -57,940.00%
Mar 31, 2025 -61,020.00%
Dec 31, 2024 -32,566.67%
Sep 30, 2024 -30,428.57%
Jun 30, 2024 -37,616.67%
Mar 31, 2024 -31,583.33%
Dec 31, 2023 -28,942.86%
Sep 30, 2023 -40,650.00%
Mar 31, 2020 -1,158.00%
API Access

GRI Bio EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=GRI&period=max&api_key=YOUR_API_KEY